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PCardiac Rhythm Disorders
redictors of Non-Pulmonary Vein
ctopic Beats Initiating Paroxysmal Atrial Fibrillation
mplication for Catheter Ablation
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OBJECTIVES The purpose of this study was to investigate the predictor of non-pulmonary vein (PV)
ectopic beats initiating paroxysmal atrial fibrillation (PAF).
BACKGROUND Non-PV ectopic beats can initiate PAF in some patients and play an important role in the
recurrence of PAF after PV isolation. Information on the predictors of non-PV ectopic beats
initiating PAF is unknown.
METHODS This study included 293 patients (215 men and 78 women, age 60  14 years) with clinically
documented drug-refractory PAF. Of the 94 patients with non-PV ectopic beats initiating
PAF, 38 (40%) patients had superior vena cava (SVC) ectopic beats and 32 (34%) had left
atrial posterior free wall (LAPFW) ectopic beats.
RESULTS In a univariate analysis, only female gender was related to the presence of non-PV (p 0.016)
and SVC ectopic beats (p  0.012). Right atrial enlargement (p  0.005) and left atrial
enlargement (p  0.001) were related to the presence of LAPFW ectopic beats. In a
multivariate analysis, female gender (p 0.043; odds ratio 2.00, 95% confidence interval [CI]
1.02 to 3.92) and left atrial enlargement (p  0.007; odds ratio 2.34, 95% CI 1.27 to 4.32)
could predict the presence of non-PV ectopic beats. Subgroup analysis showed that female
gender could predict the presence of SVC ectopic beats (p  0.039; odds ratio 2.14, 95% CI
1.04 to 4.43). In contrast, left atrial enlargement could predict the presence of LAPFW
ectopic beats (p  0.002; odds ratio 3.89, 95% CI 1.62 to 9.38).
CONCLUSIONS The location of non-PV ectopic beats initiating PAF can be predicted by both gender and left
atrial enlargement. (J Am Coll Cardiol 2005;46:1054–9) © 2005 by the American College
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.06.016of Cardiology Foundation
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aeveral studies have demonstrated that pulmonary veins
PVs) are the major site of ectopic beats initiating paroxys-
al atrial fibrillation (PAF), and isolation of the PVs from
he atrial tissue can cure 65% to 85% of patients with PAF
1–3). Non-PV ectopic beats have been proven to initiate
AF in some patients, and the presence of non-PV ectopic
eats might play an important role in the recurrence of PAF
fter PV isolation (4–7). Previous studies have also shown
hat wide-area left atrial ablation may be more effective than
imple PV isolation, because some left atrial posterior free
all (LAPFW) foci might be eliminated and/or isolated
uring circumferential ablation (8,9). Whether there are
redictors of non-PV ectopic beats initiating PAF is un-
nown. Awareness of this information may be useful in
lanning the ablation strategy. Therefore, the purpose of the
From the Department of Medicine, *National Yang-Ming University, Taipei,
aiwan, and †Fu Jen Catholic University, Hsinchuang, Taipei Hsien, Tawain; and
ivision of Cardiology, ‡Veterans General Hospital-Taipei and §Shin Kong Wu
o-Su Memorial Hospital, Taipei, Taiwan. This study was supported in part by
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SC-93-01), Taipei, Taiwan, R.O.C.f
Manuscript received March 25, 2005; revised manuscript received May 23, 2005,
ccepted May 31, 2005.tudy was to investigate the predictors of non-PV ectopic
eats initiating PAF.
ETHODS
lectrophysiologic study. This study included 293 consec-
tive patients (215 men and 78 women, age 60  14 years)
ith clinically documented PAF, who were refractory to
 1 antiarrhythmic drug. Furthermore, these patients had
ore than one episode of PAF per week in the month
efore the ablation procedure. Each patient underwent an
lectrophysiologic study in the fasting, non-sedated state
fter written, informed consent was obtained. All antiar-
hythmic drugs except amiodarone were discontinued for at
east five half-lives before the study.
We first attempted to locate the spontaneous onset of
ctopic beats initiating AF in the baseline state or after
nfusion of isoproterenol (up to 4 g/min for 5 min) (2,5,7).
f spontaneous AF did not appear, intermittent atrial pacing
8 to 12 beats) with a cycle length of 200 to 300 ms from the
igh right atrium or coronary sinus (CS) was used to
acilitate spontaneous initiation of AF after a pause in the
trial pacing. If spontaneous AF did not occur, burst pacing
rom the high right atrium or CS was used to induce
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September 20, 2005:1054–9 Predictors of Non-PV Ectopic Beats Initiating PAFustained AF. After an episode of pacing-induced AF was
ustained for 5 to 10 min, external cardioversion (starting
rom 50 J and increasing in 50-J increments for each
ubsequent trial) was attempted to convert the AF to sinus
hythm and observe the spontaneous re-initiation of AF. A
olus of high-dose adenosine (24 to 84 mg) was also used to
rovoke the spontaneous onset of AF. The onset pattern of
pontaneous AF was analyzed, and the earliest ectopic site
as considered to be the initiating focus of AF. The method
sed to provoke spontaneous AF was tried at least twice to
nsure reproducibility.
According to our study, the difference in the time interval
etween the high right atrium and His bundle atrial
ctivation obtained during sinus beats and atrial premature
eats was a good method to identify whether the ectopic
ocus was from the right or left atrium (10). Further, the
olarity of the P-wave of the ectopic beat was a useful
ethod to differentiate the location of the ectopic beats
11). Mapping of the PVs was guided by selective PV
ngiography or the venous phase of selective pulmonary
rtery angiography, with the first pair of electrodes strad-
ling the ostium. The catheters were first put into superior
Vs and then the inferior PVs if the ectopic focus was
uspected to be from the inferior PVs. We used two
ultipolar catheters to perform simultaneous mapping of
he PVs and LAPFW, if necessary. If the initiating focus of
AF was considered to be from the right atrium, we put one
uodecapolar catheter (1-mm electrode width and 2-mm
nterelectrode spacing) along the crista terminalis (CT) to
each the top of the superior vena cava (SVC) for simulta-
eous mapping of the PVs and SVC.
atheter ablation. Radiofrequency (RF) ablation was not
erformed in the patients who only had a single ectopic beat
ithout initiating AF during the electrophysiologic study.
n the patients with ectopy from the SVC, the atriocaval
unction was confirmed by an SVC venogram, intracardiac
ltrasound, and electrical signals. Isolation of the SVC was
erformed at a level about 5 mm below the atriocaval
unction (5,7). The SVC-right atrial junction exhibits an
ccentric shape, not a round shape; thus, the ablation
atheter may not contact the wall well. Application of RF
nergy at the first or second level of SVC is easier to
nterrupt the right atrium-SVC myocardial sleeve; however,
t may result in a higher risk of SVC narrowing or stenosis
Abbreviations and Acronyms
CS  coronary sinus
CT  crista terminalis
LAPFW  left atrial posterior free wall
LOM  ligament of Marshall
PAF  paroxysmal atrial fibrillation
PV  pulmonary vein
RF  radiofrequency
SVC  superior vena cava7). For the cases with a high risk of sinus node injury tacceleration of the sinus rate during SVC isolation), we
sed three-dimensional non-contact mapping to identify
he origin and exit site of the sinus node activation, as well
s to avoid the application of any energy around that area.
or ectopy from the CT, CS ostium, and interatrial septum,
unipolar QS pattern indicated the presumed ablation site.
A unipolar QS pattern also indicated the presumed
blation site for ectopy from the LAPFW. Furthermore, if
he ectopic beat was located nearby the PV ostium, we
sually extended the ablation lesion from the ostium to
ncircle part of the posterior wall with a square-shaped
around 1.5 to 2.0 cm on each side) linear lesion to ablate or
solate the ectopy. However, if the ectopic beat is located
ear the left PV ostium, the possibility of ectopy originating
rom the ligament of Marshall (LOM) should be consid-
red. In such a case, a discrete, sharp potential preceding the
eft atrial and PV potentials with “triple potentials” would be
bserved (5).
The ablation catheter (4-mm tip electrode, Boston Sci-
ntific, Watertown, Massachusetts) was connected to an
PT-1000 generator (EP Technologies, Mountain View,
alifornia) delivering a 550-kHz sine wave output.
emperature-controlled (target temperature 50°C to 55°C)
F energy was delivered for 20 to 40 s per pulse, but was
erminated immediately if the ablation catheter became
isplaced or the patient complained of burning pain,
oughed, or developed severe bradycardia. The ablation end
oint was the total elimination or marked reduction (50%
f initial amplitude) in the ectopic focus electrogram am-
litude. For patients with SVC ectopy, SVC isolation with
he disappearance of ectopy and distal SVC potential was
he end point. The protocols used to facilitate AF onset
efore ablation were repeated to assess the effects of RF
blation immediately after and 10 to 15 min after the last
pplication of RF energy. Close clinical follow-up (two
eeks, one month, and then every one to three months) was
rranged after the ablation (12).
redictors of the location of ectopic beats initiating
AF. The analyzed variables included gender, age (65 or
65 years), a history of documented PAF (5 or5 years),
he presence of other cardiovascular disease (e.g., hyperten-
ive cardiovascular disease, coronary artery disease, conges-
ive heart failure, hypertrophic cardiomyopathy, valvular
eart disease), the presence of related arrhythmias (e.g.,
trial flutter, atrial tachycardia, atrioventricular node re-
ntrant tachycardia, right atrial enlargement, left atrial
nlargement), or concurrent drug usage (e.g., beta-blocker,
alcium channel blocker, digitalis, angiotensin-converting
nzyme inhibitor). Left atrial enlargement was defined as
eft atrial diameter 40 mm on parasternal short-axis view.
tatistics analysis. Quantitative data are expressed as the
ean value  SD. The chi-square test with Yates’ correc-
ion was used to analyze the nonparametric data. For
omparisons within small groups in which the expected
umber in any of the four cells was below five, a Fisher exact
est was used. Multivariate analysis was performed with
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f the presence of ectopic beats. Variables selected to be
ested in the multivariate analysis were those with p  0.1
n the univariate model. A significant odds ratio was
btained if the 95% confidence interval (CI) exceeded 1.0
nd the p value was0.05. A p value0.05 was considered
tatistically significant.
ESULTS
ncidence of PV and non-PV ectopic beats initiating
AF. Of the 293 patients with ectopic beats initiating
AF, 199 (68%) had pure PV, 36 (12%) had pure non-PV,
nd 58 (20%) had both PV and non-PV ectopic beats
nitiating PAF. Of the 94 patients with non PV-ectopic
eats, 38 (40%) patients had SVC, 32 (34%) had LAPFW,
4 (15%) had CT, 7 (7%) had LOM, 4 (4%) had an
nteratrial septum, and 1 (1%) had a CS ostium ectopic beat
nitiating PAF. During a mean follow-up period of 52 21
onths, 67% in the patients with pure PV, 76% in those
ith pure non-PV, and 60% in those with both PV and
on-PV ectopic beats initiating PAF were free of AF
ecurrence without the use of antiarrhythmic drugs.
redictors of non-PV ectopic beats initiating PAF.
omparisons between the patients with pure PV ectopic
eats (n  199) and those with non-PV ectopic beats
nitiating AF (n  94, including patients with PV plus
on-PV and patients with pure PV ectopic beats) are shown
n Table 1. Univariate analysis revealed that only female
ender was related to the presence of non-PV ectopy
nitiating AF (p  0.016) (Table 2). Multivariate analysis
howed that female gender and left atrial enlargement could
redict the presence of non-PV ectopic beats initiating AF.
able 1. Patient Characteristics
Pure PV
(n  199)
Non
(n 
ale gender 78% 64
ge (yrs) 60  14 61 
istory of PAF (yrs) 5  5 5 
ardiovascular disease 55% 52
Hypertensive cardiovascular disease 48% 42
Coronary artery disease 18% 17
Congestive heart failure 10% 8
Hypertrophic cardiomyopathy 2% 2
Valvular heart disease 1% 1
elated arrhythmias 48% 60
Atrial flutter 45% 52
Atrial tachycardia 2% 5
Atrioventricular nodal re-entrant tachycardia 2% 3
ight atrial enlargement 15% 17
eft atrial enlargement 35% 48
oncurrent drug usage
Beta-receptor blocker 11% 17
Calcium channel blocker 21% 19
Digitalis 1% 5
Angiotensin-converting enzyme inhibitor 18% 15ata are presented as the mean value  SD or percentage of patients.
LAPFW  left atrial posterior free wall; PAF  paroxysmal atrial fibrillation; PV  pVC ectopic beats initiating PAF. Comparisons between
he patients with (n  8) and without (n  255) SVC
ctopic beats initiating AF are shown in Table 1. Univariate
nalysis showed that only female gender was related to the
resence of SVC ectopic beats (p  0.012) (Table 2).
ultivariate analysis demonstrated that only female gender
ould predict the presence of SVC ectopic beats.
APFW ectopic beats initiating PAF. Comparisons be-
ween the patients with LAPFW ectopic beats (n 32) and
hose without LAPFW ectopic beats initiating AF (n 
61) are shown in Table 1. Univariate analysis revealed that
ight atrial enlargement (p  0.005) and left atrial enlarge-
ent (p  0.001) were related to the presence of the
APFW ectopy (Table 2). Multivariate analysis showed
hat only left atrial enlargement could predict the presence
f LAPFW ectopy.
ISCUSSION
ajor findings. The present study showed that female
ender could predict the SVC ectopic beats initiating PAF
nd left atrial enlargement could predict the LAPFW
ctopic beats initiating PAF. These findings suggest that
ender and left atrial enlargement are important predictors
f non-PV AF.
emale gender predicts SVC ectopic beats initiating
AF. Sauer et al. (13) reported that women were more
ikely than men to have non-PV ectopic beats initiating
AF in 343 patients who underwent RF ablation for PAF.
he present study also showed that female gender was the
nly predictor of SVC ectopic beats initiating PAF. These
ndings suggest that female hormones might play a role in
he higher incidence of SVC ectopic beats in women.
SVC
(n  38)
Without SVC
(n  255)
LAPFW
(n  32)
Without LAPFW
(n  261)
55% 76% 78% 73%
57  13 60  14 64  12 60  14
5  4 5  5 6  5 5  5
42% 56% 66% 53%
32% 48% 50% 46%
13% 19% 22% 17%
5% 10% 13% 9%
5% 1% 0% 2%
0% 1% 0% 1%
53% 52% 63% 51%
40% 49% 63% 46%
5% 2% 0% 3%
5% 2% 0% 2%
9% 17% 34% 13%
34% 40% 72% 35%
13% 14% 19% 13%
13% 21% 26% 19%
6% 2% 7% 2%
9% 18% 19% 17%-PV
94)
%
13
5
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%
%ulmonary vein; SVC  superior vena cava.
Table 2. Univariate and Multivariate Analysis for the Presence of Non-Pulmonary Vein, Superior Vena Cava, and Left Atrial Posterior Free Wall Ectopic Beats
Variables
Non-PV (n  94) SVC (n  38) LAPFW (n  32)
Univariate Multivariate Univariate Multivariate Univariate Multivariate
p Value p Value Odds Ratio 95% CI p Value p Value Odds Ratio 95% CI p Value p Value OR 95% CI
Gender 0.016* 0.043 2.00 1.02–3.92 0.012* 0.039 2.14 1.04–4.43 0.67* — — —
Age 0.96* — — — 0.06* 0.27 — — 0.20* — — —
History of PAF 0.89* — — — 0.78* — — — 0.78* — — —
Cardiovascular disease 0.74* — — — 0.16* — — — 0.23* — — —
Hypertensive cardiovascular disease 0.40* — — — 0.08* 0.27 — — 0.77* — — —
Coronary artery disease 0.95* — — — 0.55* — — — 0.71* — — —
Congestive heart failure 0.62* — — — 0.55† — — — 0.52† — — —
Hypertrophic cardiomyopathy 0.66† — — — 0.13† — — — 1.0† — — —
Valvular heart disease 1.0† — — — 1.0† — — — 1.0† — — —
Related arrhythmias 0.09* 0.23 — — 1.0* — — — 0.28* — — —
Atrial flutter 0.34* — — — 0.37* — — — 0.11* — — —
Atrial tachycardia 0.12† — — — 0.28† — — — 0.60† — — —
Atrioventricular nodal re-entrant
tachycardia
0.39† — — — 0.18† — — — 1.0† — — —
Right atrial enlargement 0.76* — — — 0.41* — — — 0.005* 0.19 — —
Left atrial enlargement 0.08* 0.007 2.34 1.27–4.32 0.66* — — — 0.001* 0.002 3.89 1.62–9.38
Concurrent drug usage
Beta-receptor blocker 0.25* — — — 1.0† — — — 0.38† — — —
Calcium channel blocker 0.90* — — — 0.36* — — — 0.58* — — —
Digitalis 0.05† 0.09 — — 0.14† — — — 0.11† — — —
Angiotensin-converting enzyme
inhibitor
0.72* — — — 0.32* — — — 0.79† — — —
*Chi-square test with Yates’ correction. †Fisher exact test.
CI  confidence interval; other abbreviations as in Table 1.
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Predictors of Non-PV Ectopic Beats Initiating PAF September 20, 2005:1054–9owever, the effects of female hormones on automaticity
ere not reported. Furthermore, in the present study, only
of 25 premenopausal women had oral contraceptive use
nd only 8 of 53 postmenopausal women had hormone
eplacement therapy. Among the postmenopausal women,
he incidence of hormone replacement therapy was similar
etween patients with SVC ectopic beats and those without
VC ectopic beats initiating PAF (10% vs. 19%, p  0.66).
Previous studies have consistently shown that men have
igher sympathetic activity and women have higher para-
ympathetic activity (14,15). Schauerte et al. (16) also
howed that high-frequency stimulation of cardiac auto-
omic nerves in the vicinity of the canine SVC could induce
VC ectopy initiating PAF, and this phenomenon could be
bolished by atropine. We also demonstrated that an in-
rease in vagal tone induced by phenylephrine was effective
n suppressing focal PAF originating from the PVs but not
he SVC (17). These findings suggest that women with
igher parasympathetic activity might have a higher inci-
ence of SVC ectopic beats initiating AF.
eft atrial enlargement predicts LAPFW ectopic beats
nitiating PAF. The present study showed that gender
ould not predict LAPFW ectopic beats initiating PAF, but
hat left atrial enlargement could predict LAPFW ectopic
eats initiating PAF. Previous studies reported that in-
reased automaticity and increased trigger activity might
ccur in human diseased atrial fibers (18–20). Thus, it is
ossible that LAPFW could be the site of spontaneous
ctopy in patients with left atrial enlargement. Furthermore,
ased on the theory of multiple re-entrant wavelets, AF
ould be more easily induced and maintained in larger atrial
izes (21,22).
blation of non-PV ectopic beats initiating PAF. Pul-
onary vein isolation can eliminate the triggers and driving
echanisms of PAF that come from the PVs. Oral et al. (8)
nd Pappone et al. (9) showed that circumferential PV
blation, including LAPFW ablation, had better results
han PV isolation in preventing PAF. Circumferential PV
blation may eliminate ectopic foci from the LAPFW and
OM, prevent the rotors and/or spiral waves that drive AF,
nd encircle some of the left atrial myocardium and limit the
trial area for the AF wavelets in the patients with left atrial
nlargements (4,23,24). Previous studies have shown that
eural input to the LAPFW and SVC might have some
elationship to the triggering of PV foci firing (9,16,17,25).
owever, further studies are needed to clarify whether vagal
enervation produced by circumferential ablation may sup-
ress remote non-PV ectopic beats initiating PAF.
otential clinical implications. First, isolation of the PVs
as been proven to be effective in eliminating 65% to 85%
f PAF. However, non-PV ectopic beats might play an
mportant role in the initiation of PAF in some patients.
he present study showed that female gender could predict
he presence of SVC ectopic beats initiating PAF. Thus,
rovoking SVC ectopic beats initiating AF during thelectrophysiologic study is important in women. Further
tudies are needed to clarify the exact effects of female
ormones and the autonomic tone on the SVC ectopic beats
nitiating PAF. Second, the present study showed that left
trial enlargement was a predictor of LAPFW ectopic beats
nitiating AF; thus, a larger circle ablation to isolate all
ctopic beats might be considered in the patients with left
trial enlargement because the LAPFW ectopic beats were
ifficult to map. Third, the present study showed that the
ocation of non-PV ectopic beats initiating PAF could be
redicted by both gender and left atrial enlargement. How-
ver, a considerable number of the patients who had SVC
ctopic beats initiating PAF were males, and a considerable
umber of the patients with left atrial enlargement did not
ave LAPFW ectopic beats initiating PAF. Thus, a detailed
lectrophysiologic study to find the non-PV ectopic beats
nitiating PAF is necessary in all patients.
onclusions. The present study demonstrated that female
ender could predict the presence of SVC ectopic beats
nitiating PAF, and left atrial enlargement could predict
APFW ectopic beats initiating PAF. These findings
uggest the different mechanisms that might be involved in
AF initiated by ectopic beats from different locations.
eprint requests and correspondence: Dr. Shih-Huang Lee,
ivision of Cardiology, Shin Kong Wu Ho-Su Memorial Hospi-
al, 95 Wen Chang Road, Shih Lin, Taipei, Taiwan, R.O.C.
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